Use of convalescent plasma in the treatment of COVID-19

Michael J. Joyner; Nigel Paneth; Arturo Casadevall

doi:10.1038/s41581-023-00690-4

Use of convalescent plasma in the treatment of COVID-19

Michael J. Joyner, Nigel Paneth, Arturo Casadevall

Anesthesiology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	Nature Reviews Nephrology
DOIs	https://doi.org/10.1038/s41581-023-00690-4
State	Accepted/In press - 2023

ASJC Scopus subject areas

Nephrology

Access to Document

10.1038/s41581-023-00690-4

Cite this

@article{986b385cf91b4f3b82f2d09dd117b83d,

title = "Use of convalescent plasma in the treatment of COVID-19",

author = "Joyner, {Michael J.} and Nigel Paneth and Arturo Casadevall",

note = "Funding Information: M.J.J. has received a research grant from Octapharma to support the US Convalescent Plasma Program. The other authors declare no competing interests.",

year = "2023",

doi = "10.1038/s41581-023-00690-4",

language = "English (US)",

journal = "Nature Clinical Practice Nephrology",

issn = "1759-507X",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Use of convalescent plasma in the treatment of COVID-19

AU - Joyner, Michael J.

AU - Paneth, Nigel

AU - Casadevall, Arturo

N1 - Funding Information: M.J.J. has received a research grant from Octapharma to support the US Convalescent Plasma Program. The other authors declare no competing interests.

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85148219630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148219630&partnerID=8YFLogxK

U2 - 10.1038/s41581-023-00690-4

DO - 10.1038/s41581-023-00690-4

M3 - Letter

AN - SCOPUS:85148219630

SN - 1759-507X

JO - Nature Clinical Practice Nephrology

JF - Nature Clinical Practice Nephrology

ER -

Use of convalescent plasma in the treatment of COVID-19

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this